Although a recent study suggested that PPM1D may be highly expressed in poor risk AML cases [54], our results from at least 2 independent cohorts, showed high PPM1D levels in core binding factor AML and heterogeneous levels in cases with high risk and complex karyotype. Here, PPM1D is linked to acute myeloid leukemia.